PWPS
MDGL icon

Pinnacle Wealth Planning Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Sell
223
-9
-4% -$4.61K 0.01% 773
2026
Q1 		$121K Sell
232
-1
-0.4% -$478 0.01% 700
2025
Q4 		$136K Buy
+233
New +$119K 0.01% 628

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pinnacle Wealth Planning Services's MDGL Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Madrigal Pharmaceuticals (MDGL) stake by 3.9% in Q2 2026, selling an estimated $4.61K and leaving 223 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #773.

Pinnacle Wealth Planning Services first reported a position in MDGL in Q4 2025 and has held it in 3 quarters since. The position peaked at $136K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Pinnacle Wealth Planning Services held 223 shares of Madrigal Pharmaceuticals worth $120K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 9 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $4.61K.
  • Madrigal Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #773 holding.
  • Pinnacle Wealth Planning Services first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Madrigal Pharmaceuticals position peaked at $136K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.